Contineum Therapeutics, Inc.

Contineum Therapeutics, Inc.

CTNM
Contineum Therapeutics, Inc.US flagNASDAQ
16.70
USD
-0.87
- -
628.27MMarket Cap

Valuation

Price vs. fair value · multiples
Price & Valuation BandSIGNATURE
Price against a fair-value channel (EPS × 12 / 15 / 23×)
+2.9% CAGR
Not enough positive-earnings history for a fair-value band

Growth

Revenue · EPS · free cash flow
Revenue
Top line with YoY growth
RevenueYoY growth
EPS (Diluted)
Per-share earnings · loss years read red
EPSYoY growth
Free Cash Flow
Operating CF − capex, with FCF margin
Operating CFCapexFree cash flowFCF margin

Profitability

Margins & returns on capital
Gross Profit & Margin
Bars with margin trend line
No data available

Gross Profit & Margin isn’t reported for CTNM.

Operating Income & Margin
Bars with margin trend line
Operating incomeOperating margin
Net Income & Margin
Loss years read red
Net incomeNet margin
ROIC · ROE · ROA
Returns on capital · ROE on right axis
ROICROEROA

Balance Sheet Health

Liquidity · leverage · share count
Cash vs. Debt
Liquidity & leverage, net-debt line
Cash & investmentsTotal debtNet debt
Shares Outstanding
Diluted share count · buybacks vs. dilution
+11.8% CAGR
Dividends & Payout Ratio
Dividend per share with payout overlay
No data available

Dividends & Payout Ratio isn’t reported for CTNM.

roic.ai · Fundamentals charts. Figures are not investment advice.